The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mobile Cancer Screening Devices Market Research Report 2025

Global Mobile Cancer Screening Devices Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1603172

No of Pages : 87

Synopsis
Cancer screening aims to detect cancer before symptoms appear. This may involve blood tests, urine tests, DNA tests other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harms.
The global Mobile Cancer Screening Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Mobile Cancer Screening Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mobile Cancer Screening Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mobile Cancer Screening Devices include AbDent, Inc., Apteryx, Inc., Breastlight, Braster S.A., Bremed Ltd., Forward Science, MobileODT Ltd., Niramai Health Analytix and TruScreen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mobile Cancer Screening Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mobile Cancer Screening Devices.
Report Scope
The Mobile Cancer Screening Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mobile Cancer Screening Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mobile Cancer Screening Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbDent, Inc.
Apteryx, Inc.
Breastlight
Braster S.A.
Bremed Ltd.
Forward Science
MobileODT Ltd.
Niramai Health Analytix
TruScreen
UE LifeSciences
Segment by Type
Cervical Cancer
Breast Cancer
Oral Cancer
Others
Segment by Application
Home Care Settings
Specialty Clinics
Hospitals
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mobile Cancer Screening Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mobile Cancer Screening Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Mobile Cancer Screening Devices Market Overview
1.1 Product Overview and Scope of Mobile Cancer Screening Devices
1.2 Mobile Cancer Screening Devices Segment by Type
1.2.1 Global Mobile Cancer Screening Devices Market Value Comparison by Type (2024-2030)
1.2.2 Cervical Cancer
1.2.3 Breast Cancer
1.2.4 Oral Cancer
1.2.5 Others
1.3 Mobile Cancer Screening Devices Segment by Application
1.3.1 Global Mobile Cancer Screening Devices Market Value by Application: (2024-2030)
1.3.2 Home Care Settings
1.3.3 Specialty Clinics
1.3.4 Hospitals
1.4 Global Mobile Cancer Screening Devices Market Size Estimates and Forecasts
1.4.1 Global Mobile Cancer Screening Devices Revenue 2019-2030
1.4.2 Global Mobile Cancer Screening Devices Sales 2019-2030
1.4.3 Global Mobile Cancer Screening Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mobile Cancer Screening Devices Market Competition by Manufacturers
2.1 Global Mobile Cancer Screening Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mobile Cancer Screening Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mobile Cancer Screening Devices Average Price by Manufacturers (2019-2024)
2.4 Global Mobile Cancer Screening Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mobile Cancer Screening Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mobile Cancer Screening Devices, Product Type & Application
2.7 Mobile Cancer Screening Devices Market Competitive Situation and Trends
2.7.1 Mobile Cancer Screening Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mobile Cancer Screening Devices Players Market Share by Revenue
2.7.3 Global Mobile Cancer Screening Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mobile Cancer Screening Devices Retrospective Market Scenario by Region
3.1 Global Mobile Cancer Screening Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mobile Cancer Screening Devices Global Mobile Cancer Screening Devices Sales by Region: 2019-2030
3.2.1 Global Mobile Cancer Screening Devices Sales by Region: 2019-2024
3.2.2 Global Mobile Cancer Screening Devices Sales by Region: 2025-2030
3.3 Global Mobile Cancer Screening Devices Global Mobile Cancer Screening Devices Revenue by Region: 2019-2030
3.3.1 Global Mobile Cancer Screening Devices Revenue by Region: 2019-2024
3.3.2 Global Mobile Cancer Screening Devices Revenue by Region: 2025-2030
3.4 North America Mobile Cancer Screening Devices Market Facts & Figures by Country
3.4.1 North America Mobile Cancer Screening Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mobile Cancer Screening Devices Sales by Country (2019-2030)
3.4.3 North America Mobile Cancer Screening Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mobile Cancer Screening Devices Market Facts & Figures by Country
3.5.1 Europe Mobile Cancer Screening Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mobile Cancer Screening Devices Sales by Country (2019-2030)
3.5.3 Europe Mobile Cancer Screening Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mobile Cancer Screening Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Mobile Cancer Screening Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mobile Cancer Screening Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Mobile Cancer Screening Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mobile Cancer Screening Devices Market Facts & Figures by Country
3.7.1 Latin America Mobile Cancer Screening Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mobile Cancer Screening Devices Sales by Country (2019-2030)
3.7.3 Latin America Mobile Cancer Screening Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mobile Cancer Screening Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Mobile Cancer Screening Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mobile Cancer Screening Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mobile Cancer Screening Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mobile Cancer Screening Devices Sales by Type (2019-2030)
4.1.1 Global Mobile Cancer Screening Devices Sales by Type (2019-2024)
4.1.2 Global Mobile Cancer Screening Devices Sales by Type (2025-2030)
4.1.3 Global Mobile Cancer Screening Devices Sales Market Share by Type (2019-2030)
4.2 Global Mobile Cancer Screening Devices Revenue by Type (2019-2030)
4.2.1 Global Mobile Cancer Screening Devices Revenue by Type (2019-2024)
4.2.2 Global Mobile Cancer Screening Devices Revenue by Type (2025-2030)
4.2.3 Global Mobile Cancer Screening Devices Revenue Market Share by Type (2019-2030)
4.3 Global Mobile Cancer Screening Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mobile Cancer Screening Devices Sales by Application (2019-2030)
5.1.1 Global Mobile Cancer Screening Devices Sales by Application (2019-2024)
5.1.2 Global Mobile Cancer Screening Devices Sales by Application (2025-2030)
5.1.3 Global Mobile Cancer Screening Devices Sales Market Share by Application (2019-2030)
5.2 Global Mobile Cancer Screening Devices Revenue by Application (2019-2030)
5.2.1 Global Mobile Cancer Screening Devices Revenue by Application (2019-2024)
5.2.2 Global Mobile Cancer Screening Devices Revenue by Application (2025-2030)
5.2.3 Global Mobile Cancer Screening Devices Revenue Market Share by Application (2019-2030)
5.3 Global Mobile Cancer Screening Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbDent, Inc.
6.1.1 AbDent, Inc. Corporation Information
6.1.2 AbDent, Inc. Description and Business Overview
6.1.3 AbDent, Inc. Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbDent, Inc. Mobile Cancer Screening Devices Product Portfolio
6.1.5 AbDent, Inc. Recent Developments/Updates
6.2 Apteryx, Inc.
6.2.1 Apteryx, Inc. Corporation Information
6.2.2 Apteryx, Inc. Description and Business Overview
6.2.3 Apteryx, Inc. Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Apteryx, Inc. Mobile Cancer Screening Devices Product Portfolio
6.2.5 Apteryx, Inc. Recent Developments/Updates
6.3 Breastlight
6.3.1 Breastlight Corporation Information
6.3.2 Breastlight Description and Business Overview
6.3.3 Breastlight Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Breastlight Mobile Cancer Screening Devices Product Portfolio
6.3.5 Breastlight Recent Developments/Updates
6.4 Braster S.A.
6.4.1 Braster S.A. Corporation Information
6.4.2 Braster S.A. Description and Business Overview
6.4.3 Braster S.A. Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Braster S.A. Mobile Cancer Screening Devices Product Portfolio
6.4.5 Braster S.A. Recent Developments/Updates
6.5 Bremed Ltd.
6.5.1 Bremed Ltd. Corporation Information
6.5.2 Bremed Ltd. Description and Business Overview
6.5.3 Bremed Ltd. Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bremed Ltd. Mobile Cancer Screening Devices Product Portfolio
6.5.5 Bremed Ltd. Recent Developments/Updates
6.6 Forward Science
6.6.1 Forward Science Corporation Information
6.6.2 Forward Science Description and Business Overview
6.6.3 Forward Science Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Forward Science Mobile Cancer Screening Devices Product Portfolio
6.6.5 Forward Science Recent Developments/Updates
6.7 MobileODT Ltd.
6.6.1 MobileODT Ltd. Corporation Information
6.6.2 MobileODT Ltd. Description and Business Overview
6.6.3 MobileODT Ltd. Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MobileODT Ltd. Mobile Cancer Screening Devices Product Portfolio
6.7.5 MobileODT Ltd. Recent Developments/Updates
6.8 Niramai Health Analytix
6.8.1 Niramai Health Analytix Corporation Information
6.8.2 Niramai Health Analytix Description and Business Overview
6.8.3 Niramai Health Analytix Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Niramai Health Analytix Mobile Cancer Screening Devices Product Portfolio
6.8.5 Niramai Health Analytix Recent Developments/Updates
6.9 TruScreen
6.9.1 TruScreen Corporation Information
6.9.2 TruScreen Description and Business Overview
6.9.3 TruScreen Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 TruScreen Mobile Cancer Screening Devices Product Portfolio
6.9.5 TruScreen Recent Developments/Updates
6.10 UE LifeSciences
6.10.1 UE LifeSciences Corporation Information
6.10.2 UE LifeSciences Description and Business Overview
6.10.3 UE LifeSciences Mobile Cancer Screening Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 UE LifeSciences Mobile Cancer Screening Devices Product Portfolio
6.10.5 UE LifeSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mobile Cancer Screening Devices Industry Chain Analysis
7.2 Mobile Cancer Screening Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mobile Cancer Screening Devices Production Mode & Process
7.4 Mobile Cancer Screening Devices Sales and Marketing
7.4.1 Mobile Cancer Screening Devices Sales Channels
7.4.2 Mobile Cancer Screening Devices Distributors
7.5 Mobile Cancer Screening Devices Customers
8 Mobile Cancer Screening Devices Market Dynamics
8.1 Mobile Cancer Screening Devices Industry Trends
8.2 Mobile Cancer Screening Devices Market Drivers
8.3 Mobile Cancer Screening Devices Market Challenges
8.4 Mobile Cancer Screening Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’